1.
Kader S, J.Al-Shamma K, A. Majeed I, T. Al-Ani A. Comparative Study between Oral Hypoglycemic Drugs Repaglinide, Glibenclamide and Rosiglitazone on Some Biochemical Parameters in Type 2 Diabetic Patients. Iraqi Journal of Pharmaceutical Sciences . 2017;18(2):32-38. doi:10.31351/vol18iss2pp32-38